Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
7.64
+0.45 (6.26%)
At close: Sep 1, 2025

SHA:688373 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
5,0093,2374,2795,805--
Upgrade
Market Cap Growth
44.22%-24.35%-26.30%---
Upgrade
Enterprise Value
4,8422,8003,4434,701--
Upgrade
Last Close Price
7.644.946.538.86--
Upgrade
PS Ratio
36.6924.8547.13120.42--
Upgrade
PB Ratio
15.987.375.134.78--
Upgrade
P/TBV Ratio
16.057.405.144.79--
Upgrade
EV/Sales Ratio
35.4721.5037.9397.53--
Upgrade
Debt / Equity Ratio
1.130.690.270.190.370.01
Upgrade
Asset Turnover
0.150.130.070.050.01-
Upgrade
Inventory Turnover
0.460.500.560.540.09-
Upgrade
Quick Ratio
2.283.057.1411.135.0319.32
Upgrade
Current Ratio
2.673.537.7211.915.4119.93
Upgrade
Return on Equity (ROE)
-78.12%-69.24%-41.12%-26.66%-42.75%-30.31%
Upgrade
Return on Assets (ROA)
-26.52%-27.18%-20.63%-15.00%-25.55%-16.18%
Upgrade
Return on Capital (ROIC)
-29.57%-30.53%-22.00%-15.75%-27.45%-18.44%
Upgrade
Earnings Yield
-7.55%-13.62%-9.84%-3.79%--
Upgrade
FCF Yield
-6.79%-13.84%-7.87%-4.34%--
Upgrade
Buyback Yield / Dilution
-1.55%--13.09%-10.17%-106.16%-12.82%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.